Common Cold

Join Clinical Trials for Common Cold

Join Clinical Trials for Common Cold

General Purpose:

We’ve all had it at least once in our lives: the common cold. It’s not fun, leaves us feeling drained and dreary, and brings with it a multitude of ever-changing symptoms that rarely respond well to the most well-intentioned treatment.

Unfortunately, there is no cure for the common cold, due to the fact that over 200 different viruses can cause its symptoms to develop. However, a particular group of viruses, known as Rhinoviruses, cause between 30% and 50% of all colds.Therefore, research related to the Rhinoviruses is plentiful, and scientists have discovered a wealth of information about this group of viruses.

Due to this increased understanding, research related to the common cold often focuses on the development of new anti-viral drugs, the development and testing of new technologies to detect and analyze viruses in individuals who have cold-related symptoms, and studies designed to help people better manage the symptoms of this widespread problem.

Continued … Common Cold Clinical Trials (Click to Open)

Join Clinical Trials for Common Cold

Common Cold Clinical Trials

What Will Common Cold Clinical Trials Be like?

When participating in a clinical trial designed to investigate some aspect related to the common cold, a few common tests and procedures may be involved; however, the ultimate design of the particular study will determine which specific procedures you will undergo.

Documentation of symptoms will likely occur, as will monitoring of your symptoms’ severity and how long they persist. A physical examination may be required so that the study doctors can listen to your lungs, as well as feel and view your sinuses for signs of inflammation. A manual lymph node exam may also be performed, during with the doctor places his hands along the sides of your neck, below your ears, and along your throat to feel for swollen lymph nodes.

Sputum/spit samples, as well as blood samples, may also be taken. They may be analyzed to determine the virus causing the symptoms, as well as the types and levels of antibodies from your immune system that are presenting and fighting the infection.

Typical Common Cold Clinical Trial Protocol:

Current research related to the common cold is broad in scope and covers a wide range Common Cold Clinical Trialsof topics. Specific examples might include the following types of studies:

  • A study designed to investigate the effectiveness of a new medication designed to suppress coughing and reduce mucus production.
  • A study designed to determine the effectiveness of various behavioral interventions designed to help prevent the development of the common cold, including hand washing, sanitary sneezing practices, and the use of disinfectants in the home.
  • A trial designed to determine the effectiveness of alternative and natural therapies, such as Echinacea, vitamin C, and zinc in preventing the development of a cold, or shortening the duration of its symptoms.
  • A study designed to evaluate individual characteristics that might make an individual more susceptible to developing a cold, such as body weight, disease status (i.e., underlying diabetes, cystic fibrosis, asthma), age, environmental factors, and occupational exposures.

Suggested Search Terms:

“common cold treatment,” “common cold vitamin C,” “common cold zinc,” “common cold prevention,” and “common cold hygiene.”

Current Search Term:

“Common Cold”



The Effect of Zinc Acetate Lozenges on the Rate of Recovery From the Common Cold


Conditions:   Common Cold;   Respiratory Tract Infections
Interventions:   Device: Lozenges;   Device: Placebo lozenges
Sponsors:   Helsinki University;   The University Pharmacy, Helsinki
Not yet recruiting


Efficacy and Safety Study of Ingavirin® to Treat Influenza and Acute Respiratory Viral Infections in Patients 13-17 y.o.


Conditions:   Influenza, Human;   Acute Respiratory Infection;   Viral Infection;   Common Cold
Interventions:   Drug: Ingavirin;   Drug: Placebo oral capsule
Sponsor:   Valenta Pharm JSC
Completed


Efficacy and Safety Study of Ingavirin® 90 mg Once Daily to Treat Influenza and Other Acute Viral Infections in Adults


Conditions:   Common Cold;   Influenza, Human;   Acute Respiratory Infection
Interventions:   Drug: Ingavirin;   Drug: Placebo
Sponsor:   Valenta Pharm JSC
Completed


Efficacy and Safety of Regan Tangjiang for Treating the Common Cold With Wind-heat Syndrome


Condition:   Cold
Intervention:   Drug: Regan Tangjiang
Sponsor:   Beijing Da-an Bio-technology Co., Ltd.
Not yet recruiting


Echinaforce Junior Bioavailability Trial


Condition:   Common Cold
Intervention:   Drug: Echinaforce junior
Sponsors:   Bioforce AG;   University Children's Hospital, Zurich
Recruiting


To Evaluate the Efficacy and Safety of 1146A Nasal Spray in Adult Participants With Symptoms of Common Cold


Condition:   Common Cold
Interventions:   Drug: Carbomer 980 (1146A);   Other: Placebo
Sponsor:   GlaxoSmithKline
Completed


PEAC: Phytus Efficacy in Acute Cough


Conditions:   Cough;   Common Cold
Intervention:   Drug: Phytus (Cisti, Thyme and Ivy Leaves)
Sponsor:   PharmEvo Pvt Ltd
Not yet recruiting


Rapid Diagnostics for Upper Respiratory Infections in the Emergency Department


Conditions:   Respiratory Tract Infections;   Influenza, Human;   Common Cold
Intervention:   Device: Rapid respiratory pathogen nucleic acid amplification test
Sponsors:   University of California, Davis;   BioFire Diagnostics, LLC
Recruiting


Desloratadine,Phenylephrine Hcl,Ibuprofen Compared to Placebo in Treatment of Symptoms Associated With Common Cold/Flu


Condition:   Cold
Interventions:   Drug: Desloratadine+Phenylephrine+Ibuprofen;   Drug: Placebo
Sponsor:   Ache Laboratorios Farmaceuticos S.A.
Not yet recruiting


Local Nasal Tolerability and Safety Study of 1146A in Healthy Adult Participants


Condition:   Common Cold
Interventions:   Drug: Carbomer 980;   Other: Placebo
Sponsor:   GlaxoSmithKline
Completed


Warming Sensation and Tolerability Study of Acetylcysteine 2% Oral Solution for Productive Cough


Condition:   Common Cold
Intervention:   Drug: Acetylcystine
Sponsor:   GlaxoSmithKline
Completed


Effect of Probiotic on Rhinovirus Induced Colds


Condition:   Common Cold
Interventions:   Biological: Bifidobacterium animalis subsp. lactis Bl-04;   Other: sucrose
Sponsors:   University of Virginia;   Danisco Sweeteners Oy
Enrolling by invitation


Effect of OC459 on the Response to Rhinovirus Challenge in Asthma


Conditions:   Asthma;   Rhinovirus;   Picornaviridae Infections;   Common Cold
Interventions:   Drug: OC459;   Drug: Placebo;   Other: Rhinovirus
Sponsors:   Imperial College London;   Medical Research Council;   Atopix Therapeutics, Ltd.
Recruiting


Efficacy & Tolerability of a Specific Plantain,Thyme and Honey Cough Syrup vs Placebo in Child Cough Due to Common Cold


Condition:   Cough
Interventions:   Device: Cough syrup for adults and children;   Device: Placebo
Sponsor:   Clalit Health Services
Completed


Safety and Intake Effect of EPs® 7630 (an Extract of the Roots of Pelargonium Sidoides)


Condition:   Common Cold
Interventions:   Drug: EPs® 7630;   Drug: Placebo
Sponsor:   Dr. Willmar Schwabe GmbH & Co. KG
Completed


Micronutrient Supplementation and Incidence of Common Cold


Condition:   Immune System Diseases
Interventions:   Dietary Supplement: vitamines and minerals;   Dietary Supplement: placebo
Sponsors:   Green Beat;   Medical University of Graz
Completed


Effect of Probiotic on the Innate and Adaptive Host Response to Rhinovirus (EPIARR)


Condition:   Common Cold
Interventions:   Dietary Supplement: Bifidobacterium lactis Bl-04;   Dietary Supplement: Placebo;   Biological: Rhinovirus
Sponsors:   University of Virginia;   DuPont Nutrition and Health
Completed


Intranasal SB-705498 in Non-allergic Rhinitis Patients


Condition:   Rhinitis
Interventions:   Drug: Placebo;   Drug: SB-705498
Sponsor:   GlaxoSmithKline
Completed


Efficacy and Safety of Combination of Brompheniramine and Phenylephrine for the Symptoms Relief of Rhinitis


Conditions:   Nasal Congestion and Inflammations;   Rhinitis
Interventions:   Drug: Group 1;   Drug: Group 2
Sponsor:   Ache Laboratorios Farmaceuticos S.A.
Completed


Acute Cough Study In Children


Conditions:   Common Cold;   Infections, Upper Respiratory Tract
Interventions:   Drug: Dextromethorphan;   Drug: Placebo
Sponsors:   Pfizer;   AccuDial Pharmaceutical;   Boehringer Ingelheim;   McNeil Consumer Healthcare Division of McNEIL-PPC, Inc.;   Novartis;   Perrigo Company;   Procter and Gamble;   Reckitt Benckiser LLC
Terminated


Study to Evaluate the Efficacy and Safety of Fixed Dose Combination of Diphenhydramine + Pseudoephedrine + Dropropizine in the Control of Cough and the Relief of Nasal Symptoms, Suffering From Non-productive Cough and Acute Rhinitis


Conditions:   Nasal Congestion;   Cough
Interventions:   Drug: Group 1;   Drug: Group 2
Sponsor:   Ache Laboratorios Farmaceuticos S.A.
Withdrawn


Placebo and Active Controlled Study to Assess Efficacy and Tolerability of Aspirin Plus Pseudoephedrine


Conditions:   Common Cold;   Pharyngitis
Interventions:   Drug: Acetylsalicylic Acid (Aspirin Complex, BAYE4465) + Pseudoephedrine;   Drug: Acetylsalicylic Acid (Aspirin, BAYE4465);   Drug: Pseudoephedrine;   Drug: Placebo
Sponsor:   Bayer
Completed


Efficacy Study of A Lotion to Prevent Common Colds


Conditions:   Common Cold;   Healthy
Intervention:   Drug: 3804-250A
Sponsors:   The Dial Corporation;   Hill Top Research
Unknown status


Oxymetazoline Hydrochloride in Combination With Nasal Glucocorticosteroid for Perennial Allergic and Non-allergic Rhinitis in Subjects With Persistent Nasal Congestion


Condition:   Chronic Rhinitis
Intervention:   Drug: Oxymetazoline Hydrochloride
Sponsor:   University of South Florida
Terminated


Singulair Use in Non-Allergic Rhinitis Eosinophil Syndrome (NARES)


Condition:   Rhinitis
Interventions:   Drug: montelukast;   Drug: placebo
Sponsors:   Bernstein, Jonathan A., M.D.;   Merck Sharp & Dohme Corp.
Unknown status

Refine Your Search Advanced Search